[Molecular diagnostics of lung cancer and its clinical relevance].

Abstract excerpt

Molecular classification of lung cancer developed in the past decades to the level where even the rare genetic alterations are included. Unfortunately, adenocarcinoma benefited from this development almost exclusively. Furthermore, the tumor-agnostic novel therapy indications influence the molecular diagnostics of lung cancer including microsatellite status, tumor mutation burden or NTRK fusion gene...

Topics

• Biomarkers, Tumor
• High-Throughput Nucleotide Sequencing
• Humans
• Lung Neoplasms
• Molecular Targeted Therapy
• Mutation
• Pathology, Molecular